The p21 WAF1/CIP1 gene, which encodes a cyclin-dependent kinase inhibitor, may be critical for tumor suppressor gene p53-induced cell cycle arrest. The p53 gene is known to regulate G 1 checkpoint, which can either induce G 1 arrest or initiate apoptosis. To directly examine the role of p21 WAF1/CIP1 in the control of p53 function, we have introduced human p21 WAF1/CIP1 gene into a p53-de®cient human non-small cell lung cancer cell line H1299 using a p21
WAF1/CIP1
-expressing adenoviral vector (AdCMVp21). Infection with AdCMVp21 resulted in high levels of p21 WAF1/CIP1 expression and signi®cantly suppressed the growth of H1299 cells through the G 1 arrest of the cell cycle. In contrast, transient expression of the wild-type p53 gene by a recombinant adenoviral vector (AdCMVp53) in H1299 cells induced apoptotic cell death and resulted in a rapid loss of cell viability. We then examined the eects of combined infection with AdCMVp21 and AdCMVp53 on H1299 cells to explore the dominant function of these molecules. Interestingly, introduction of exogenous p53 overcame p21
-mediated cell cycle arrest at G 1 and induced apoptosis, although viral-transduced p21 WAF1/CIP1 expression level was unaected. These observations suggest that p53 expression converts a p21 WAF1/CIP1 -mediated growth arrest into apoptosis. The result was repeated with two additional human colon adenocarcinoma cell lines with the dierent p53 status, mutant p53-expressing DLD-1 and wild-type p53-expressing LoVo, suggesting that this phemonenon is a general event among human cancer cells. Thus, p53-mediated apoptotic pathway is dominant over the growth arrest pathway, indicating that p53 may be an essential upstream mediator of p21

Introduction
Apoptosis is de®ned by morphologic changes, such as condensation and margination of chromatin concomitant with cell shrinkage, that are clearly distinct from necrosis; these changes are followed by a characteristic intranucleosomal DNA fragmentation resulting from cleavage of nuclear DNA. Although apoptosis is a part of normal development involving nonpathologic cell death, it also is involved in the cytotoxic mechanism of anticancer treatments. Recent studies have demonstrated that at least two pathways regulate apoptosis: one dependent on the tumor suppressor gene p53 and the other p53-independent (Clarke et al., 1993) . Inactivation of p53 by point mutation or deletion is among the commonest genetic abnormalities in human cancer. Overexpression of wild-type p53 induces apoptotic cell death of tumor cells devoid of wildtype p53 or expressing mutant p53, although the response depends on cell type and experimental conditions (Fujiwara et al., 1993) . To develop speci®c strategies for anticancer therapy, it may be important to explore the molecular basis of p53-mediated apoptosis.
Cloning and characterization of the p21
gene, which is induced by p53, have revealed that its protein product p21 potently regulates the cell cycle by inhibiting cyclin-dependent kinases (Cdk) required for progression from the G 1 to the S phase (Harper et al., 1993; El-Deiry et al., 1993) , and also inhibits the ability of proliferating-cell nuclear antigen to activate DNA polymerase d, resulting in inhibition of DNA replication (Waga et al., 1994) . In addition, it has been shown that p21 WAF1/CIP1 is induced following upregulation of p53 expression in the process of apoptosis triggered by DNA damage (El-Deiry et al., 1994) . Recent studies using p21-de®cient ®broblasts obtained from mice lacking p21 WAF1/CIP1 as well as the p21-de®cient human colon cancer cells created by a homologous deletion of p21 WAF1/CIP1 have demonstrated that p21 WAF1/CIP1 is a critical mediator of p53-dependent G 1 arrest associated with DNA damage; the ®nding that p21-null mouse thymocytes are sensitive to g-irradiationinduced apoptosis, however, suggests that p53-dependent apoptosis may not require p21 WAF1/CIP1 (Deng et al., 1995; Waldman et al., 1995) . Indeed, forced expression of the Cdk inhibitors has been reported to protect against apoptosis in differentiating murine myocytes (Wang and Walsh, 1996) and in human colon cancer cells treated with prostaglandin A 2 (Gorospe et al., 1996) .
In the present study, to gain a further insight of p21 WAF1/CIP1 functions in the regulation of the cell cycle and apoptosis by p53, we used a recombinant adenoviral vector expressing the human p53 or p21 WAF1/CIP1 gene. We found that p21
overexpression induces a stable growth arrest in three human cancer cell lines diering their p53 status, and also explored the eects of ectopic wild-type p53 expression on this p21 WAF1/CIP1 -mediated G 1 arrest.
Results
Eect of p53 or p21
WAF1/CIP1 expression on human cancer cell lines Replication-de®cient adenoviral vectors were chosen to achieve ecient gene transfer into cells at all stages of the cell cycle. Monolayer p53-de®cient H1299 human nonsmall cell lung cancer cells were infected at a multiplicity of infection (MOI) of 50 with either AdRSVLuc, AdCMVp53, or AdCMVp21 for 24 h. Western blot analysis was performed to compare the levels of each protein (Figure 1 ). AdCMVp53-infected H1299 cells showed high levels of both p53 and p21 proteins 48 h after infection, suggesting that the virally transduced p53 induced endogenous p21
. In contrast, only p21 protein was detected in AdCMVp21-infected cells. Neither parental nor AdRSVLuc-infected H1299 cells expressed detectable p53 or p21 protein. Although detectable levels of p53 or p21 protein were observed a day after infection, the kinetics of p53 or p21 expression showed a distinctly dierent pattern. The level of p53, as previously reported , reached a maximum 3 days after AdCMVp53 infection followed by a rapid decrease; AdCMVp21, however, caused a gradual increase of p21 protein expression, which was maintained for at least 15 days (data not shown).
To assess the eects of AdCMVp53 or AdCMVp21 infection, cells which remained as an attached monolayer were assessed for viability by measuring trypan blue uptake for 6 days following infection with AdCMVp53 or AdCMVp21 for 24 h. A rapid loss of cell viability due to massive cell death, as evidenced bȳ oating, highly light-refractile cells, was observed in AdCMVp53-infected H1299 cells, while AdCMVp21 signi®cantly reduced cell growth rates and induced morphologic changes such as an increased cytoplasmicto-nuclear ratio ( Figure 2 ). AdRSVLuc-infected H1299 cells retained both a morphology and a growth rate similar to uninfected cells.
Growth suppression mediated by p21
WAF1/CIP1 and p53-mediated cell death are caused by G 1 arrest and apoptosis
To further study the mechanism of p21 WAF1/CIP1 -induced growth arrest and p53-mediated cell death, H1299 cells were infected with either AdCMVp21 or AdCMVp53, harvested at 48 h post-infection, and then assayed for DNA content by¯ow cytometry and for intranucleosomal DNA cleavage. Representative cell cycle pro®les of cells stained with propidium iodide are shown in Figure 3a . Neither untreated proliferating cells nor AdRSVLuc-infected cells showed a speci®c pattern in the cell cycle distribution; the cells infected with AdCMVp53, however, exhibited a DNA content less than the diploid, G 0 /G 1 peak, indicating nuclear fragmentation. In contrast, after AdCMVp21 infection, cells showed a decreased fraction of S-phase cells resulting from an accumulation of most cells at G 0 /G 1 , indicative of G 1 arrest. This p21-mediated block of the cell cycle apparently continued as long as p21 was induced (data not shown). Although the morphologic changes of p53-transduced H1299 cells resembled those identi®ed in the apoptotic death pathway, isolated DNA was analysed by electrophoresis through an agarose gel to obtain an additional indication of apoptosis ( Figure 3b ). The characteristic DNA ladder, a hallmark of apoptotic cell death, appeared after AdCMVp53 infection, but not in cells similarly infected with AdCMVp21. We also looked for the eect of AdCMVp53 and AdCMVp21 on human colon carcinoma cell lines diering in their p53 status: mutant p53-expressing DLD-1 and LoVo which contained wild-type p53. Flowcytometric analysis has demonstrated that infection with AdCMVp53 induced a complete apoptosis in DLD-1 and LoVo cells by 48 h, whereas cell cycle arrest at the G 1 phase was observed in both cell lines after AdCMVp21 infection (data not shown).
Apoptosis mediated by p53 can overcome p21
To investigate the eect of p21 WAF1/CIP1 overexpression on p53-mediated apoptotic cell death in three human cancer cell lines, AdCMVp21 and AdCMVp53 infections were performed in sequence. Five 6 10 4 H1299 cells cultured as a monolayer were infected with AdCMVp21 at a MOI of 50 for 24 h to be arrested in G 1 , further exposed to either AdCMVp53 or AdRSVLuc in the same condition (50 MOI) 2 days after the ®rst infection, and then assessed for cell viability over 5 days. Double infection with both AdCMVp21 and AdCMVp53 was carried out at a MOI of 100 for each viruses on DLD-1 and LoVo colon cancer cells. Previous work has showed that the range of adenovirus infectivity varies among cell types . A preliminary titration study using serially diluted viral stocks demonstrated that infectious condition at a MOI of 100 achieved an ecient eect on these two cell lines. The growth rate of H1299, DLD-1, and LoVo cells was signi®cantly reduced after the ®rst AdCMVp21 infection and most cells stopped growing by 48 h; however, following additional AdCMVp53 transduction, viability of cells rapidly declined over 72 h (Figure 4) , suggesting that infection with AdCMVp21 prior to AdCMVp53 showed little eect on AdCMVp53-mediated cell killing. There was no apparent toxicity in AdCMVp21/AdRSVLuc-infected cells, and cells showed no morphologic changes compared to uninfected cells (data not shown).
H1299, DLD-1, and LoVo cells were sequentially infected with two types of adenoviral vectors in the same experimental condition described above, and studied by a¯ow cytometry after the second infection to follow the cell-cycle events during p53-mediated apoptosis. We examined whether cells arrested in G 1 phase promote cell cycle again in the process of apoptosis. As shown in Figure 5 , cells expressing p21 WAF1/CIP1 constitutively stayed in G 1 phase at least for To examine whether expression of an adenoviraltransduced p21 protein is aected by subsequent AdCMVp53 infection, extracts of cells sequentially infected with the two adenoviral vectors were subjected to Western analysis. H1299 cells co-infected with AdCMVp21 and AdCMVp53 showed high levels of p21 protein, similarly to those with AdCMVp21 infection alone, suggesting that AdCMVp53 infection did not aect AdCMVp21-infected exogenous p21 WAF1/ CIP1 expression ( Figure 6 ).
Discussion
Apoptosis, also known as programmed cell death, plays a major role in development, tissue regeneration, and the cytotoxicity of anticancer therapy. To understand apoptotic cell death, it seems important to de®ne the links between cell proliferation and cell death, and to clarify the mechanism by which a cell chooses either life or death. The balance between these two processes decides the fate of each cell and apparently plays a critical role to determine the therapeutic ecacy of anticancer therapy. Levels of p53 protein increase in response to DNA-damaging anticancer stimuli, and the augmented p53 levels resulted in inhibition of cell division or apoptosis. Induction of p21 protein has been reported to occur in cells undergoing either p53-mediated G 1 arrest or apoptosis (El-Deiry et al., 1994), suggesting that p21 might mediate some or all of the known functions of p53. The study presented here employed an adenoviral vector expressing p53 or p21 WAF1/CIP1 to assess the speci®c impact of these genes on cell-cycle control as well as apoptosis.
Increased levels of p21 WAF1/CIP1 expression are known to be associated with cell-cycle arrest in normal cells under physiologic conditions (Harper et al., 1993) . We have demonstrated that overexpression of p21
itself induces a cell-cycle arrest of three human cancer cell lines diering in their p53 status (H1299, DLD-1, and LoVo) at G 1 phase, and that p21 WAF1/CIP1 expression alone is not sucient to trigger the apoptotic process. The failure to induce apoptosis by overexpression of p21 WAF1/CIP1 previously has been reported Chen et al., 1995) ; our system using these cells, however, is unique because cells expressing p53 underwent complete apoptotic cell death in spite of p53-induced endogenous p21 WAF1/CIP1 expression. What determines whether a particular cell chooses cycle arrest or suicide is not fully understood. Signals that positively regulate the cell growth, such as activation of the proto-oncogene c-myc and the overexpression of E2F, abrogate p53-induced G 1 arrest and trigger apoptosis (Hermeking et al., 1994; Wu and Levine, 1994) . In contrast, excess retinoblastoma (Rb) protein, which negatively regulates the cell cycle, has been shown to suppress p53-mediated apoptosis (Haupt et al., 1995) . These ®ndings support the hypothesis that signal con¯icts may trigger apoptosis and that cells successfully arrested in G 1 may be resistant to apoptosis. A link between decreased levels of p21 and an increased tendency toward apoptosis has been recently reported in a growth factor-dependent murine hematopoietic cell line (Canman et al., 1995) . In addition, increased levels of Cdk inhibitors such as p21 WAF1/CIP1 and p16 INK4A fail to block Rb phosphorylation, rendering Rb constitutively active, and inhibiting apoptosis during myocyte dierentiation (Wang and Walsh, 1996) . These observations suggest that alteration in p21 WAF1/CIP1 expression may account for occurrence of growth arrest rather than apoptosis, and led us to examine the eect of augmented p21 WAF1/ CIP1 expression on p53-mediated apoptosis. associated with apoptosis, such as inappropriate Sphase entry without mitosis (Waldman et al., 1996) ; our¯ow cytometric analysis, however, demonstrated a rapid increase in the sub-G 0 /G 1 population following AdCMVp53 infection without any changes of the Sphase cell population. Thus, p53 might directly induce apoptosis in cells stably remaining in the G 1 phase. These ®ndings clearly suggest that in this system the apoptotic program is not triggered by signal con¯ict and that the functional activity of p53 appears to be directly coupled with cell-death induction. To the best of our knowledge, this is the ®rst report that described the mechanism of p53-mediated apoptosis completely independent of cell cycling. Moreover, the result was consistent on three human cancer cell lines diering in their genetic status: H1299 cells derived from a human large cell lung carcinoma expressing mutant N-ras and de®cient of p53; DLD-1 cells derived from a human colon carcinoma expressing mutant K-ras, mutant p53 and slightly increased level of c-myc; and LoVo cells derived from a human colon carcinoma expressing mutant K-ras, wild-type p53, and increased level of cmyc. Therefore, the dominance of apoptosis over cell cycle arrest is a general phenomenon among human cancer cells, in which ectopic p53 expression resulted in the apoptotic response.
Other interesting ®ndings in our experiments are morphologic changes of AdCMVp21-infected H1299 cells such as an increased cytoplasmic-to-nuclear ratio. Cells arrested in G 1 phase by AdCMVp21 also showed increased adherence (data not shown). These are consistent with characteristics of cells with a terminally dierentiated or senescent phenotype. Previous studies demonstrated that retinoblastoma and osteosarcoma cells infected with the wild-type Rb-expressing retrovirus as well as glioblastoma cells transfected with p53 exhibited similar morphological changes (Huang et al., 1988; Gomez-Manzano et al., 1996) . These observations suggest that cellular dierentiation and senescence can be proposed as one of the tumor suppressor mechanism. Thus, functional exploration of p21 WAF1/CIP1 itself might have implications for the development of a novel anticancer modality.
In summary, exogenous overexpression of wild-type p53 in human cancer cells could overcome a stable cell cycle arrest and resulted in a complete apoptotic cell death. Thus, p53 gene transfer may have a signi®cant clinical implication as a potential therapeutic agent. Recently, a phase I trial of the replication-defective retrovirus-mediated wild-type p53 gene therapy for non-small cell lung cancer has been reported . The results reported here suggest the possible mechanism of this novel anticancer strategy and may provide a key to the successful cancer therapy.
Materials and methods
Cells and culture conditions
The following cell lines were used: a human non-small cell lung cancer cell line H1299, which has homozygously deleted p53; a human colon carcinoma cell line DLD-1, which exhibits a homozygous p53 gene mutation; and a human colon carcinoma cell line LoVo, which contains wild-type p53. These cells were routinely propagated in monolayer culture in RPMI 1640 medium supplemented with 10% fetal calf serum, 25 mM HEPES, 100 units/ml penicillin, and 100 mg/ml streptomycin. The transformed embryonic kidney cell line 293 was grown in Dulbecco'smodi®ed Eagle's Medium (D-MEM) (Gibco, Grand Island, New York) with high glucose (4.5 g/l), supplemented with 10% fetal calf serum, 100 units/ml penicillin, and 100 mg/ ml streptomycin.
Recombinant adenoviruses
The recombinant adenoviral vector expressing human p53 or p21 WAF1/CIP1 was previously constructed and characterized Fujiwara et al., 1994; Eastman et al., 1995) . Brie¯y, the plasmid containing the cytomegalovirus promoter, the wild-type human p53 or p21 WAF1/CIP1 cDNA, and the SV40 polyadenylation signal was cotransfected with pJM17 into 293 cells by liposome/DNA coprecipitation to generate an adenoviral p53 or p21 WAF1/CIP1 expression vector. The resultant viruses were named AdCMVp53 or AdCMVp21. An adenoviral vector containing luciferase cDNA (AdRSVLuc) was used as a control vector. Culture supernatants of the viral stocks were quanti®ed by a plaque-forming assay using 293 cells. The viruses were aliquotted and stored at 7808C.
Western blot analysis
Attached cells collected by trypsinization and cells¯oating in the culture medium were combined in a 10 ml conical tube and washed twice in cold phosphate-buered saline (PBS). Cells were then lysed in SDS solubilization buer (62.5 mM Tris-HCl, pH 6.8, containing 10% glycerol, 5% bmercaptoethanol, and 2% SDS Sigma, St. Louis, MO). Equal amounts of proteins were boiled for 5 min and electrophoresed under reducing conditions on a 12.5% (w/v) polyacrylamide gel. Proteins were electrophoretically transferred to a Hybond-polyvinylidence di¯uoride (PVDF) transfer membrane (Amersham, Arlington Heights, Illinois), and incubated with primary antibody against p53 (Ab-2) or p21WAF1 (Ab-1) (Oncogene Science, Manhasset, New York) followed by peroxidase-linked secondary antibody. An Amersham ECL chemiluminescent western system (Amersham) was used to detect secondary probes. 
Flow cytometric analysis
Trypsinized adherent and¯oating cells were collected, washed twice with cold PBS, and resuspended in PBS containing 0.1% Triton X-100 and 1 g/l RNase for 5 min at RT. Samples were then stained with propidium iodide at 50 mg/ml and analysed in a cell sorter (FACScan, Becton Dickinson, Mountain View, California) for DNA content. Cell debris and ®xation artifacts were gated out, and G 1 , S, and G 2 /M populations were quanti®ed using the ModFit LT program for Mac Ver. 1.01 (Verity Software House, Inc.).
Electrophoretic analysis of DNA fragmentation
Both adherent and¯oating cells were harvested, washed twice with ice-cold phosphate saline buer, and incubated at 558C for 6 h in lysis buer (100 mM Tris-HCl, pH 8.5, 5 mM EDTA, 200 mM NaCl, 0.2% SDS and 100 mg/ml proteinase K). DNA was extracted twice with equal volumes of phenol-chloroform-isoamylalchol (25:24:1). DNA was then precipitated in ethanol. Samples were electrophoresed on a 1.5% agarose gel and visualized by ethidium bromide staining.
